Search results
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs
CBS 47 Fresno· 58 minutes agoThe World Health Organization and drugmaker Eli Lilly and Co. are warning people to be wary of fake...
Lilly files additional lawsuits over US sales of counterfeit Mounjaro
WHTC 1450 Holland· 8 hours ago(Reuters) - U.S. drugmaker Eli Lilly on Thursday said it was suing six more U.S. medical spas,...
Eli Lilly warns about dangers of fake and counterfeit Mounjaro, Zepbound
ABC News· 9 hours agoThe company also announced new lawsuits against wellness centers and medical spas advertising these...
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
Zacks via Yahoo Finance· 6 hours agoLilly currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank...
Eli Lilly Broadens Crackdown on Fake and Compounded Zepbound
Bloomberg· 9 hours agoHave a confidential tip for our reporters? Eli Lilly & Co. broadened its effort to crack down on...
Lilly files suit against more spas, weight-loss centers selling knockoff version of its popular...
Indianapolis Business Journal· 12 hours agoJust one month after settling with a South Carolina medical spa that was selling knockoff versions of its popular diabetes and weight-loss drugs, Eli Lilly
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster | The Motley Fool
The Motley Fool· 5 days agoEli Lilly's (LLY -0.55%) name has become somewhat synonymous with its work in diabetes and obesity...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 7 days agoBUSINESS In early 2018, Dave Ricks, the chief executive of the pharmaceutical giant Eli Lilly was on...
Mounjaro Is Targeting Another Multibillion-Dollar Market: Is Eli Lilly Stock a Buy? | The Motley...
The Motley Fool· 5 days agoOccasionally, some pharmaceutical companies hit the jackpot and launch medicines worth all that...
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
CNBC· 3 days agoSkyrocketing demand for a class of weight loss and diabetes treatments has lifted Eli Lilly to new...